Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery: Potentiating effect on platelet preservation

Kazuhiro Hashimoto, Tatsuumi Sasaki, Takashi Hachiya, Katsuhisa Onoguchi, Hiromitsu Takakura, Ryuichi Nagahori, Motohiro Oshiumi, Sigeyuki Takeuchi

Research output: Contribution to journalArticle

Abstract

Aprotinin administration with or without a heparin-coated circuit is expected to modulate subclinical plasma coagulation and fibrinolysis and platelet function during cardiopulmonary bypass. We studied the effect of the application of both, either one, or neither of an aprotinin prime (100 million KIU) and heparin-coated circuit in 32 consecutive patients undergoing coronary artery bypass surgery randomly divided into four groups of 8 patients each. Aprotinin was not used with the non-heparin-coated circuit in the control group. Levels of fibrinopeptide A were significantly lower in the heparin-coated circuit groups (P < 0.05-0.01), irrespective of an aprotinin prime. D-dimer levels in the control group were significantly higher than in the other groups (P < 0.05-0.01). The preservation rates of platelet count and function (acceleration of coagulation by platelet activating factor) in the control group were significantly lower than in the other three groups (P < 0.05-0.01). Platelet preservation in the aprotinin plus heparin-coated group was significantly better than in the aprotinin only and the heparin-coated only groups (P < 0.05). The amount of mediastinal drainage and the units of blood transfusion were significantly reduced in the two aprotinin groups, irrespective of heparin-coated use (P < 0.01). The values in the aprotinin plus heparin-coated group were significantly less than the values in the heparin-coated only group (P < 0.05). The heparin-coated circuit was beneficial for suppressing subclinical plasma coagulation and fibrinolysis and for preserving platelets. Addition of the minimal-dose aprotinin prime further preserved platelet function and offered the possibility of bringing about a further reduction in postoperative blood loss and blood requirements.

Original languageEnglish
Pages (from-to)157-162
Number of pages6
JournalJournal of Artificial Organs
Volume2
Issue number2
Publication statusPublished - 1999

Fingerprint

Aprotinin
Platelets
Hemostasis
Surgery
Thoracic Surgery
Heparin
Blood Platelets
Networks (circuits)
Coagulation
Blood
Fibrinolysis
Control Groups
Fibrinopeptide A
Plasmas
Postoperative Hemorrhage
Platelet Activating Factor
Cardiopulmonary Bypass
Platelet Count
Coronary Artery Bypass
Blood Transfusion

Keywords

  • Aprotinin
  • Cardiopulmonary bypass
  • Heparin-coated

ASJC Scopus subject areas

  • Biophysics

Cite this

Hashimoto, K., Sasaki, T., Hachiya, T., Onoguchi, K., Takakura, H., Nagahori, R., ... Takeuchi, S. (1999). Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery: Potentiating effect on platelet preservation. Journal of Artificial Organs, 2(2), 157-162.

Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery : Potentiating effect on platelet preservation. / Hashimoto, Kazuhiro; Sasaki, Tatsuumi; Hachiya, Takashi; Onoguchi, Katsuhisa; Takakura, Hiromitsu; Nagahori, Ryuichi; Oshiumi, Motohiro; Takeuchi, Sigeyuki.

In: Journal of Artificial Organs, Vol. 2, No. 2, 1999, p. 157-162.

Research output: Contribution to journalArticle

Hashimoto, K, Sasaki, T, Hachiya, T, Onoguchi, K, Takakura, H, Nagahori, R, Oshiumi, M & Takeuchi, S 1999, 'Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery: Potentiating effect on platelet preservation', Journal of Artificial Organs, vol. 2, no. 2, pp. 157-162.
Hashimoto, Kazuhiro ; Sasaki, Tatsuumi ; Hachiya, Takashi ; Onoguchi, Katsuhisa ; Takakura, Hiromitsu ; Nagahori, Ryuichi ; Oshiumi, Motohiro ; Takeuchi, Sigeyuki. / Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery : Potentiating effect on platelet preservation. In: Journal of Artificial Organs. 1999 ; Vol. 2, No. 2. pp. 157-162.
@article{4fcb919e0cd948ea945f5b622c6d6c7a,
title = "Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery: Potentiating effect on platelet preservation",
abstract = "Aprotinin administration with or without a heparin-coated circuit is expected to modulate subclinical plasma coagulation and fibrinolysis and platelet function during cardiopulmonary bypass. We studied the effect of the application of both, either one, or neither of an aprotinin prime (100 million KIU) and heparin-coated circuit in 32 consecutive patients undergoing coronary artery bypass surgery randomly divided into four groups of 8 patients each. Aprotinin was not used with the non-heparin-coated circuit in the control group. Levels of fibrinopeptide A were significantly lower in the heparin-coated circuit groups (P < 0.05-0.01), irrespective of an aprotinin prime. D-dimer levels in the control group were significantly higher than in the other groups (P < 0.05-0.01). The preservation rates of platelet count and function (acceleration of coagulation by platelet activating factor) in the control group were significantly lower than in the other three groups (P < 0.05-0.01). Platelet preservation in the aprotinin plus heparin-coated group was significantly better than in the aprotinin only and the heparin-coated only groups (P < 0.05). The amount of mediastinal drainage and the units of blood transfusion were significantly reduced in the two aprotinin groups, irrespective of heparin-coated use (P < 0.01). The values in the aprotinin plus heparin-coated group were significantly less than the values in the heparin-coated only group (P < 0.05). The heparin-coated circuit was beneficial for suppressing subclinical plasma coagulation and fibrinolysis and for preserving platelets. Addition of the minimal-dose aprotinin prime further preserved platelet function and offered the possibility of bringing about a further reduction in postoperative blood loss and blood requirements.",
keywords = "Aprotinin, Cardiopulmonary bypass, Heparin-coated",
author = "Kazuhiro Hashimoto and Tatsuumi Sasaki and Takashi Hachiya and Katsuhisa Onoguchi and Hiromitsu Takakura and Ryuichi Nagahori and Motohiro Oshiumi and Sigeyuki Takeuchi",
year = "1999",
language = "English",
volume = "2",
pages = "157--162",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery

T2 - Potentiating effect on platelet preservation

AU - Hashimoto, Kazuhiro

AU - Sasaki, Tatsuumi

AU - Hachiya, Takashi

AU - Onoguchi, Katsuhisa

AU - Takakura, Hiromitsu

AU - Nagahori, Ryuichi

AU - Oshiumi, Motohiro

AU - Takeuchi, Sigeyuki

PY - 1999

Y1 - 1999

N2 - Aprotinin administration with or without a heparin-coated circuit is expected to modulate subclinical plasma coagulation and fibrinolysis and platelet function during cardiopulmonary bypass. We studied the effect of the application of both, either one, or neither of an aprotinin prime (100 million KIU) and heparin-coated circuit in 32 consecutive patients undergoing coronary artery bypass surgery randomly divided into four groups of 8 patients each. Aprotinin was not used with the non-heparin-coated circuit in the control group. Levels of fibrinopeptide A were significantly lower in the heparin-coated circuit groups (P < 0.05-0.01), irrespective of an aprotinin prime. D-dimer levels in the control group were significantly higher than in the other groups (P < 0.05-0.01). The preservation rates of platelet count and function (acceleration of coagulation by platelet activating factor) in the control group were significantly lower than in the other three groups (P < 0.05-0.01). Platelet preservation in the aprotinin plus heparin-coated group was significantly better than in the aprotinin only and the heparin-coated only groups (P < 0.05). The amount of mediastinal drainage and the units of blood transfusion were significantly reduced in the two aprotinin groups, irrespective of heparin-coated use (P < 0.01). The values in the aprotinin plus heparin-coated group were significantly less than the values in the heparin-coated only group (P < 0.05). The heparin-coated circuit was beneficial for suppressing subclinical plasma coagulation and fibrinolysis and for preserving platelets. Addition of the minimal-dose aprotinin prime further preserved platelet function and offered the possibility of bringing about a further reduction in postoperative blood loss and blood requirements.

AB - Aprotinin administration with or without a heparin-coated circuit is expected to modulate subclinical plasma coagulation and fibrinolysis and platelet function during cardiopulmonary bypass. We studied the effect of the application of both, either one, or neither of an aprotinin prime (100 million KIU) and heparin-coated circuit in 32 consecutive patients undergoing coronary artery bypass surgery randomly divided into four groups of 8 patients each. Aprotinin was not used with the non-heparin-coated circuit in the control group. Levels of fibrinopeptide A were significantly lower in the heparin-coated circuit groups (P < 0.05-0.01), irrespective of an aprotinin prime. D-dimer levels in the control group were significantly higher than in the other groups (P < 0.05-0.01). The preservation rates of platelet count and function (acceleration of coagulation by platelet activating factor) in the control group were significantly lower than in the other three groups (P < 0.05-0.01). Platelet preservation in the aprotinin plus heparin-coated group was significantly better than in the aprotinin only and the heparin-coated only groups (P < 0.05). The amount of mediastinal drainage and the units of blood transfusion were significantly reduced in the two aprotinin groups, irrespective of heparin-coated use (P < 0.01). The values in the aprotinin plus heparin-coated group were significantly less than the values in the heparin-coated only group (P < 0.05). The heparin-coated circuit was beneficial for suppressing subclinical plasma coagulation and fibrinolysis and for preserving platelets. Addition of the minimal-dose aprotinin prime further preserved platelet function and offered the possibility of bringing about a further reduction in postoperative blood loss and blood requirements.

KW - Aprotinin

KW - Cardiopulmonary bypass

KW - Heparin-coated

UR - http://www.scopus.com/inward/record.url?scp=0347564171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347564171&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0347564171

VL - 2

SP - 157

EP - 162

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 2

ER -